首页> 外文期刊>Human mutation >Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.
【24h】

Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.

机译:急性骨髓性白血病衍生的SMAD4突变将蛋白质靶向泛素-蛋白酶体降解。

获取原文
获取原文并翻译 | 示例
       

摘要

Disruption of transforming growth factor-beta (TGFB1/TGF-beta) signaling contributes to the formation of human hematological malignancies. Smad4, a tumor suppressor, functions as an essential intracellular signal transducer of the TGF-beta signaling pathway. Recent studies have demonstrated that some tumor-derived mutations of Smad4 are associated with protein instability; however, the precise mechanism by which mutated Smad4 proteins undergo rapid degradation remains to be elucidated. A missense mutation of the SMAD4 gene in the Mad homology 1 (MH1) domain (c.305C>T, Pro102Leu) and one frameshift mutation resulting in termination in the Mad homology 2 (MH2) domain (c.1447_1448insAATA, Delta483-552) have been identified in acute myelogenous leukemia. It is not known whether protein instability of these SMAD4 mutants is one of the contributors to TGF-beta signaling disruption in acute myelogenous leukemia. Here we report that these two acute myelogenous leukemia-derived SMAD4 mutants are degraded rapidly when compared to their wild-type counterpart. We have demonstrated that both mutated proteins exhibit enhanced polyubiquitination (or polyubiquitylation) and proteasomal degradation. Importantly, we found that beta-transducin-repeat-containing protein 1 (beta-TrCP1), an F-box protein in the ubiquitin E3 ligase Skp1-Cullin-F-box protein (SCF) complex, directly interacts with and acts as a critical determinant for degradation of both mutated SMAD4 proteins. In addition, small interference RNA (siRNA)-triggered endogenous beta-TrCP1 suppression increased the protein expression level of both overexpressed SMAD4 mutants and endogenous mutated SMAD4 protein in acute myelogenous leukemia cells. These data suggest that mutated SMAD4 proteins undergo rapid degradation in acute myelogenous leukemia cells via SCF(beta-TrCP1) E3 ligase-mediated protein ubiquitination (or ubiquitylation) and subsequent proteasomal degradation.
机译:转化生长因子-β(TGFB1 /TGF-β)信号的破坏有助于人类血液恶性肿瘤的形成。 Smad4,一种肿瘤抑制物,起着TGF-beta信号通路必不可少的细胞内信号转导子的作用。最近的研究表明,Smad4的一些肿瘤来源的突变与蛋白质不稳定有关。然而,突变的Smad4蛋白经历快速降解的确切机制仍有待阐明。 Mad同源1(MH1)域(c.305C> T,Pro102Leu)中SMAD4基因的错义突变和一个移码突变导致Mad同源2(MH2)域终止(c.1447_1448insAATA,Delta483-552)已在急性骨髓性白血病中得到鉴定。这些SMAD4突变体的蛋白质不稳定性是否是急性骨髓性白血病中TGF-β信号转导的促成因素之一,这一点尚不清楚。在这里,我们报告这两个急性骨髓性白血病衍生的SMAD4突变体与其野生型对应物相比迅速降解。我们已经证明,这两种突变蛋白都表现出增强的多泛素化(或多泛素化)和蛋白酶体降解。重要的是,我们发现含泛素E3连接酶Skp1-Cullin-F-box蛋白(SCF)复合体中的F-box蛋白含有β-转导蛋白重复蛋白1(beta-TrCP1)与之直接相互作用并充当两种突变的SMAD4蛋白降解的关键决定因素。此外,小干扰RNA(siRNA)触发的内源性β-TrCP1抑制增加了急性骨髓性白血病细胞中过表达的SMAD4突变体和内源性突变的SMAD4蛋白的蛋白质表达水平。这些数据表明突变的SMAD4蛋白通过SCF(β-TrCP1)E3连接酶介导的蛋白泛素化(或泛素化)和随后的蛋白酶体降解在急性粒细胞性白血病细胞中迅速降解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号